01.08.2017
- AstraZeneca has entered into a global collaboration with US drugmaker Merck to develop and commercialize the former’s investigational cancer treatments Lynparza (olaparib) and...
27.02.2017
- The US Food and Drug Administration (FDA) has accepted Swiss pharmaceutical major Novartis’ supplemental New Drug Application (sNDA) for filing and granted priority review for the...
22.02.2017
- Chinese drugmaker Qilu Pharmaceutical has introduced a new targeted therapy generic cancer medicine, geftinib, which is claimed to be effective against non-small cell lung cancer...
08.09.2016
- Allergan has acquired “substantially all” of the assets of RetroSense Therapeutics, a private, clinical-stage biotechnology company focused on novel gene therapy approaches to...
08.08.2016
- Pfizer has acquired the remaining stake in Bamboo Therapeutics, a privately held gene therapy group based in Chapel Hill, North Carolina, USA, in a deal that could be worth as much...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
19.11.2015
- A further regulatory milestone has been achieved by Merck KGaA and Pfizer after the US Food and Drug Administration (FDA) designated their potential skin cancer treatment avelumab...
07.10.2015
- Kemal Malik, board member for innovation at the German Bayer Group, sees many similarities in the genetic system of humans, animals and plants. This opens the door for synergies in...
